Neoadjuvant Herceptin recommended for locally advanced breast cancer
29 January 2010
| by Tony James
Adding neoadjuvant trastuzumab to chemotherapy should be considered in women with HER2-positive locally advanced breast cancer, the European NOAH trial has concluded....
Want to read complete article? Please Sign in or Register.